Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of Rocatinlimab compared to Placebo to help adults with Moderate to Severe Asthma
BulgariaStudy on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases
CzechiaStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
BulgariaStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
BelgiumStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
AustriaStudy of Elafibranor in Adults with Primary Biliary Cholangitis Who Don't Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment
CzechiaStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
CzechiaStudy of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma
DenmarkStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
